Literature DB >> 28144693

[Phase III study for local or locally advanced prostate cancer : Randomized, double-blind, placebo-controlled phase 3 study of apalutamide in patients with local high-risk prostate cancer or locally advanced prostate cancer receiving primary radiotherapy (ATLAS) - study AP 90/15 of the AUO].

H Rexer1, M Graefen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28144693     DOI： 10.1007/s00120-017-0329-0

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  2 in total

Review 1.  Emerging therapeutic agents for genitourinary cancers.

Authors:  Kevin Zarrabi; Azzam Paroya; Shenhong Wu
Journal:  J Hematol Oncol       Date:  2019-09-04       Impact factor: 17.388

2.  Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719).

Authors:  Giulio Francolini; Beatrice Detti; Vanessa Di Cataldo; Pietro Garlatti; Michele Aquilano; Andrea Allegra; Sara Lucidi; Cecilia Cerbai; Lucia Pia Ciccone; Viola Salvestrini; Giulia Stocchi; Barbara Guerrieri; Luca Visani; Mauro Loi; Isacco Desideri; Monica Mangoni; Icro Meattini; Lorenzo Livi
Journal:  Radiol Med       Date:  2022-06-28       Impact factor: 6.313
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.